| Courtney E Barbier, AUD | |
|
8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810-7828 | |
| (225) 408-6900 | |
| (225) 408-6946 |
| Full Name | Courtney E Barbier |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 2 Years |
| Location | 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043949084 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Louisiana Ear Nose Throat And Sinus Llc | 9335473685 | 26 |
News Archive
WellCare Health Plans, Inc. today reported results for the three and six months ended June 30, 2010. As determined under generally accepted accounting principles, the Company reported a second quarter 2010 net loss of $128.9 million, or $3.05 per diluted share, compared with net income of $37.0 million, or $0.88 per diluted share, for the prior year period.
Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.
The more rainfall a region in sub-Saharan Africa gets, the more mosquitoes proliferate there and the more likely its residents will sleep under their insecticide-treated bed nets to prevent malaria transmission, a new study from the Johns Hopkins Center for Communication Programs suggests.
Europe is at the forefront of acknowledging the importance of patient safety and risk management. Eight to 10 percent of patients in the region are subjected to healthcare-associated infections and medication or prescription errors. Around 30 to 40 percent of these issues are preventable, and healthcare institutions have rolled out several initiatives for reporting and learning systems, as well as patient safety directives. Denmark in particular has shown considerable progress, followed closely by the U.K. and France.
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.
› Verified 8 days ago
| Provider Name | Louisiana Ear Nose Throat & Sinus Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114483872 PECOS PAC ID: 9335473685 Enrollment ID: O20190620002368 |
News Archive
WellCare Health Plans, Inc. today reported results for the three and six months ended June 30, 2010. As determined under generally accepted accounting principles, the Company reported a second quarter 2010 net loss of $128.9 million, or $3.05 per diluted share, compared with net income of $37.0 million, or $0.88 per diluted share, for the prior year period.
Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.
The more rainfall a region in sub-Saharan Africa gets, the more mosquitoes proliferate there and the more likely its residents will sleep under their insecticide-treated bed nets to prevent malaria transmission, a new study from the Johns Hopkins Center for Communication Programs suggests.
Europe is at the forefront of acknowledging the importance of patient safety and risk management. Eight to 10 percent of patients in the region are subjected to healthcare-associated infections and medication or prescription errors. Around 30 to 40 percent of these issues are preventable, and healthcare institutions have rolled out several initiatives for reporting and learning systems, as well as patient safety directives. Denmark in particular has shown considerable progress, followed closely by the U.K. and France.
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney E Barbier, AUD 604 N Acadia Rd Ste 101, Thibodaux, LA 70301-4897 Ph: (854) 465-0799 | Courtney E Barbier, AUD 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810-7828 Ph: (225) 408-6900 |
News Archive
WellCare Health Plans, Inc. today reported results for the three and six months ended June 30, 2010. As determined under generally accepted accounting principles, the Company reported a second quarter 2010 net loss of $128.9 million, or $3.05 per diluted share, compared with net income of $37.0 million, or $0.88 per diluted share, for the prior year period.
Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.
The more rainfall a region in sub-Saharan Africa gets, the more mosquitoes proliferate there and the more likely its residents will sleep under their insecticide-treated bed nets to prevent malaria transmission, a new study from the Johns Hopkins Center for Communication Programs suggests.
Europe is at the forefront of acknowledging the importance of patient safety and risk management. Eight to 10 percent of patients in the region are subjected to healthcare-associated infections and medication or prescription errors. Around 30 to 40 percent of these issues are preventable, and healthcare institutions have rolled out several initiatives for reporting and learning systems, as well as patient safety directives. Denmark in particular has shown considerable progress, followed closely by the U.K. and France.
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.
› Verified 8 days ago
Shelby Carbo, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5258 Dijon Dr, Baton Rouge, LA 70808 Phone: 225-769-1090 | |
Scallan Hearing Aid & Audiology Center Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8211 Goodwood Blvd, Suite B, Baton Rouge, LA 70806 Phone: 225-925-0373 Fax: 225-925-9410 | |
Anna Katherine Miller, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5258 Dijon Dr, Baton Rouge, LA 70808 Phone: 225-769-1090 Fax: 225-769-5514 | |
Jane V Schmolke, M.A. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Suite 2222, Baton Rouge, LA 70810 Phone: 225-408-6900 Fax: 225-757-8061 | |
Lsu Speech, Language And Hearing Clinic Audiologist Medicare: Not Enrolled in Medicare Practice Location: 63 Hatcher Hl, Lsu Department Of Communication Sciences And Disorders, Baton Rouge, LA 70803 Phone: 225-578-9054 Fax: 225-578-2995 | |
Mary E Gilly, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9001 Summa Ave, Baton Rouge, LA 70809 Phone: 225-761-5200 Fax: 225-761-5344 |